THROMBOCYTOPENIA
Clinical trials for THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising prostate cancer trial pulled before it began
Disease control TerminatedThis study aimed to test a radioactive drug, 177Lu-PSMA-617, in men with advanced prostate cancer that had spread to the bone marrow and caused low blood counts. The goal was to see if the treatment was safe and how it affected the cancer. However, the study was withdrawn before …
Matched conditions: THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:29 UTC
-
ITP drug study halted before it began
Disease control TerminatedThis study was designed to test an experimental drug called HMPL-523 in adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding problems. The goal was to see if the drug is safe and can raise platelet counts. However, th…
Matched conditions: THROMBOCYTOPENIA
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated May 18, 2026 12:10 UTC
-
COVID vaccine clot study scrapped before start
Knowledge-focused TerminatedThis study aimed to collect medical information from people who developed unusual blood clots within four weeks of receiving a COVID-19 vaccine. The goal was to better understand any possible link between the vaccine and these rare events. However, the study was withdrawn before …
Matched conditions: THROMBOCYTOPENIA
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated May 26, 2026 08:41 UTC